INT240788

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.37
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 8
Total Number 15
Disease Relevance 7.35
Pain Relevance 0.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

molecular_function (Bcl2a1c) cellular_component (Bcl2a1c) biological_process (Bcl2a1c)
Anatomy Link Frequency
blood 2
Bcl2a1c (Mus musculus)
Pain Link Frequency Relevance Heat
Calcium channel 8 56.00 Quite High
Pain 8 20.36 Low Low
cva 8 15.00 Low Low
Bile 24 5.00 Very Low Very Low Very Low
drug abuse 8 5.00 Very Low Very Low Very Low
aspirin 2 5.00 Very Low Very Low Very Low
corticosteroid 2 5.00 Very Low Very Low Very Low
neuralgia 2 5.00 Very Low Very Low Very Low
cINOD 2 5.00 Very Low Very Low Very Low
anesthesia 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Diabetes Mellitus 721 100.00 Very High Very High Very High
Hyperglycemia 96 98.84 Very High Very High Very High
Obesity 39 98.78 Very High Very High Very High
Hypoglycemia 91 98.64 Very High Very High Very High
Stroke 65 95.28 Very High Very High Very High
Insulin Resistance 17 90.40 High High
Body Weight 21 89.84 High High
Disorder Of Lipid Metabolism 92 89.48 High High
Diabetes Complications 26 87.68 High High
Albuminuria 43 81.16 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
There is a tendency for greater A1C variability in subjects with poor glycemic control, and our study showed a strong correlation between A1C variability and baseline A1C as well as mean A1C over 12 months.
Gene_expression (variability) of A1C
1) Confidence 0.37 Published 2010 Journal Korean Diabetes Journal Section Body Doc Link PMC2898931 Disease Relevance 0.49 Pain Relevance 0
However, in multiple regression analysis, A1C variability was not a significant independent risk factor for the progression of IMT (?
Gene_expression (variability) of A1C
2) Confidence 0.32 Published 2010 Journal Korean Diabetes Journal Section Body Doc Link PMC2898931 Disease Relevance 0.39 Pain Relevance 0
There is a tendency for greater A1C variability in subjects with poor glycemic control, and our study showed a strong correlation between A1C variability and baseline A1C as well as mean A1C over 12 months.
Gene_expression (variability) of A1C
3) Confidence 0.32 Published 2010 Journal Korean Diabetes Journal Section Body Doc Link PMC2898931 Disease Relevance 0.49 Pain Relevance 0
Individual A1C variability was defined as the standard deviation (SD) of five A1C levels taken every three months for about one year.


Gene_expression (levels) of A1C
4) Confidence 0.32 Published 2010 Journal Korean Diabetes Journal Section Body Doc Link PMC2898931 Disease Relevance 0.42 Pain Relevance 0
Clinical and biochemical characteristics according to A1C variability
Gene_expression (variability) of A1C
5) Confidence 0.32 Published 2010 Journal Korean Diabetes Journal Section Body Doc Link PMC2898931 Disease Relevance 0.42 Pain Relevance 0
Change of A1C over 12 months
Gene_expression (over) of A1C
6) Confidence 0.32 Published 2010 Journal Korean Diabetes Journal Section Body Doc Link PMC2898931 Disease Relevance 0.16 Pain Relevance 0.03
There is a tendency for greater A1C variability in subjects with poor glycemic control, and our study showed a strong correlation between A1C variability and baseline A1C as well as mean A1C over 12 months.
Gene_expression (variability) of A1C
7) Confidence 0.32 Published 2010 Journal Korean Diabetes Journal Section Body Doc Link PMC2898931 Disease Relevance 0.57 Pain Relevance 0
There is a tendency for greater A1C variability in subjects with poor glycemic control, and our study showed a strong correlation between A1C variability and baseline A1C as well as mean A1C over 12 months.
Gene_expression (variability) of A1C
8) Confidence 0.32 Published 2010 Journal Korean Diabetes Journal Section Body Doc Link PMC2898931 Disease Relevance 0.49 Pain Relevance 0
For A1C values <6.2%, the presence of micro/macroalbuminuria did not confer additional risk, while significant biological interaction between A1C and micro/macroalbuminuria for values ?
Gene_expression (values) of A1C
9) Confidence 0.15 Published 2008 Journal Diabetes Care Section Abstract Doc Link PMC2584184 Disease Relevance 1.12 Pain Relevance 0
An ANCOVA model with treatment and concomitant antidiabetes medication status as fixed effects and baseline A1C as a covariate was used to evaluate the treatment effect.
Gene_expression (effects) of A1C
10) Confidence 0.07 Published 2008 Journal Diabetes Care Section Body Doc Link PMC2494667 Disease Relevance 0 Pain Relevance 0
A significantly greater percentage of subjects in the colesevelam group achieved an A1C reduction ?
Gene_expression (reduction) of A1C
11) Confidence 0.07 Published 2008 Journal Diabetes Care Section Body Doc Link PMC2494667 Disease Relevance 0 Pain Relevance 0
Because they identify only averages and not whether the person had severe extreme blood glucose readings, A1C/eAG results are of no value in predicting short-term complications of diabetes and thus have no use in evaluating individuals in employment situations.
Gene_expression (results) of A1C in blood associated with diabetes mellitus
12) Confidence 0.06 Published 2010 Journal Diabetes Care Section Body Doc Link PMC2797379 Disease Relevance 0.37 Pain Relevance 0
After 6 months of hyperglycemia, diabetic mOpsinhAng2 mice showed significantly elevated levels of blood glucose (nondiabetic versus diabetic mOpsinhAng2 mice: 184.6 ± 19.0 and 575.0 ± 40.9 mg/dl, P < 0.001) and A1C (nondiabetic versus diabetic mOpsinhAng2 mice: 5.7 ± 0.5 and 10.7 ± 2.1%, P < 0.001) compared with their nondiabetic litters.
Gene_expression (levels) of A1C in blood associated with hyperglycemia and diabetes mellitus
13) Confidence 0.05 Published 2008 Journal Diabetes Section Body Doc Link PMC2518502 Disease Relevance 1.80 Pain Relevance 0
The American Diabetes Association recommends that in most patients A1C levels be kept below 7% (4), or eAG below 154 mg/dl.
Gene_expression (levels) of A1C associated with diabetes mellitus
14) Confidence 0.05 Published 2010 Journal Diabetes Care Section Body Doc Link PMC2797379 Disease Relevance 0.45 Pain Relevance 0
These include, age, gender, level of education, income, marital/partner status, diabetes duration, BMI, medication (i.e., insulin), physical disability index, and A1C levels.
Gene_expression (levels) of A1C associated with diabetes mellitus and obesity
15) Confidence 0.01 Published 2010 Journal Trials Section Body Doc Link PMC2824703 Disease Relevance 0.20 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox